Company News
CuraTeQ Biologics Signs EU Biosimilars Distribution Deal
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed a marketing and distribution agreement with STADA Arzneimittel AG.
STADA will market and distribute two EMA-approved biosimilar
